B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndrome
- 1 June 2014
- journal article
- Published by Elsevier in Journal of Autoimmunity
- Vol. 51, 89-98
Abstract
No abstract availableKeywords
Funding Information
- S. Niarchos Foundation
- Greek Rheumatology Society
This publication has 39 references indexed in Scilit:
- Sjogren’s syndrome: An update on clinical, basic and diagnostic therapeutic aspectsJournal of Autoimmunity, 2012
- B-cell tolerance breakdown in Sjögren's Syndrome: Focus on BAFFAutoimmunity Reviews, 2010
- The geoepidemiology of Sjögren's syndromeAutoimmunity Reviews, 2010
- An important role for B-cell activation factor and B cells in the pathogenesis of Sjögren's syndromeCurrent Opinion in Rheumatology, 2007
- Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictorsAnnals of the Rheumatic Diseases, 2006
- Autoimmune and Chronic Inflammatory Disorders and Risk of Non-Hodgkin Lymphoma by SubtypeJNCI: Journal of the National Cancer Institute, 2006
- The Risk of Lymphoma Development in Autoimmune DiseasesArchives of internal medicine (1960), 2005
- Long‐term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndromeArthritis & Rheumatism, 2002
- Clinical evolution, and morbidity and mortalityof primary Sjögren's syndromeSeminars in Arthritis and Rheumatism, 2000
- Malignant lymphoma in primary Sj gren's syndrome: A multicenter, retrospective, clinical study by the European concerted action on Sj gren's syndromeArthritis & Rheumatism, 1999